Partnership with EMBLEM

Gene Predictis’s announces a partnership with the Enterprise Management Technology Transfer EMBL Company , in Heidelberg, Germany. The EMBL is the European Centre for Molecular Biology.
Cooperation aims at the development of innovative technologies to appraise, in a faster and accurate way, findings of fundamental genetics and convey them to the patient/customer.
Dr Lars Steinmetz, chairman of the Functional Genomics Department, and member of our scientific board, is heading to develop innovative devices for genetics diagnosis leading to application in personalised medicine.

Predictive medicine inferred from genetics